An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institutes of Health)
Researchers from New York University have engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and being tracked by magnetic resonance imaging (MRI). The innovation falls into the category of "theranostics," meaning that it combines diagnostic capability and drug delivery, allowing researchers to administer therapy while also non-invasively monitoring the therapeutic progress and drastically reducing the need for surgical intervention.
